Edition:
United States

Hybio Pharmaceutical Co Ltd (300199.SZ)

300199.SZ on Shenzhen Stock Exchange

15.01CNY
26 May 2017
Change (% chg)

¥0.15 (+1.01%)
Prev Close
¥14.86
Open
¥14.96
Day's High
¥15.15
Day's Low
¥14.80
Volume
3,614,485
Avg. Vol
5,498,731
52-wk High
¥23.54
52-wk Low
¥14.25

Latest Key Developments (Source: Significant Developments)

Hybio Pharmaceutical receives patent license
3:44am EDT 

May 29(Reuters) - Hybio Pharmaceutical Co Ltd <300199.SZ> ::* Says co received a patent license (No.ZL 2013 1 0219049.1.  Full Article

Hybio Pharmaceutical receives patent license
Tuesday, 9 May 2017 01:55am EDT 

May 9(Reuters) - Hybio Pharmaceutical Co Ltd <300199.SZ> ::* Says co received a patent license (No.ZL 2013 10196587.3), for the manufacturing method of Kahalalide F.  Full Article

Hybio Pharmaceutical to pay cash div 1 yuan per 10 shares for FY 2016
Thursday, 27 Apr 2017 04:46am EDT 

April 27 (Reuters) - Hybio Pharmaceutical Co Ltd <300199.SZ> ::* Says it plans to pay cash div 1 yuan per 10 shares for FY 2016.  Full Article

Hybio Pharmaceutical's Q1 net profit down 4.4 pct y/y
Wednesday, 26 Apr 2017 09:41am EDT 

April 26 (Reuters) - Hybio Pharmaceutical Co Ltd <300199.SZ>:Says its Q1 net profit down 4.4 percent y/y at 291.9 million yuan ($42.36 million).  Full Article

Hybio Pharmaceutical sees FY 2017 Q1 net profit to increase by 20 pct to 40 pct
Tuesday, 11 Apr 2017 04:48am EDT 

Hybio Pharmaceutical Co Ltd <300199.SZ> : Says net profit for FY 2017 Q1 to increase by 20 percent to 40 percent, or to be 70.3 million yuan to 82.1 million yuan, compared to net profit of FY 2016 Q1 (58.6 million yuan) .Says increased sales revenue as main reason for the forecast.  Full Article

Hybio Pharmaceutical to issue corporate bonds worth up to 1 bln yuan
Tuesday, 28 Feb 2017 12:48am EST 

Hybio Pharmaceutical Co Ltd <300199.SZ> : Says it plans to issue public corporate bonds worth up to 1 billion yuan in total, with a term of no more than 5 years .Says proceeds will be used for working capital supplement and loan repayment.  Full Article

Hybio Pharmaceutical sees FY 2016 net profit up 0 pct to 30 pct
Monday, 23 Jan 2017 12:45am EST 

Hybio Pharmaceutical Co., Ltd.<300199.SZ>: Sees net profit for FY 2016 to increase by 0 percent to 30 percent, or to be 305.3 million yuan to 396.9 million yuan . Says the net profit of FY 2015 was 305.3 million yuan .Comments that development of overseas market is the main reason for the forecast.  Full Article

Hybio Pharmaceutical's METHOD FOR SOLID PHASE SYNTHESIS OF LIRAGLUTIDE gets patent in EU
Tuesday, 27 Dec 2016 09:38pm EST 

Hybio Pharmaceutical Co., Ltd.<300199.SZ>:Says the co's METHOD FOR SOLID PHASE SYNTHESIS OF LIRAGLUTIDE received patent in Europe.  Full Article

Hybio Pharmaceutical raises 660 mln yuan via private placement
Thursday, 13 Oct 2016 10:09pm EDT 

Hybio Pharmaceutical Co Ltd <300199.SZ> :Says it issues 28.3 million new shares via private placement and raises about 660 million yuan in total.  Full Article

Hybio Pharmaceutical receives patent license
Monday, 26 Sep 2016 06:07am EDT 

Hybio Pharmaceutical <300199.SZ>:Says it received a patent license (No. ZL 2013 1 0425340.4), for a manufacturing method of sitagliptin and its intermediate.  Full Article

More From Around the Web

BRIEF-Hybio Pharmaceutical receives patent license

* Says co received a patent license (No.ZL 2013 1 0219049.1 ), for method for measuring chloride ion content of amino acid-N-formic anhydride